POLUZZI, ELISABETTA
POLUZZI, ELISABETTA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di IIa fascia
'Use of antipsychotics in children and adolescents: A picture from the ARITMO population-based European cohort study'
2020 Kaguelidou F.; Holstiege J.; Schink T.; Bezemer I.; Poluzzi E.; Mazzaglia G.; Pedersen L.; Sturkenboom M.; Trifiro G.
A 3 year survey on the use of antibacterial agents in five Italian hospitals.
2008 Vaccheri A; Silvani MC; Bersaglia L; Motola D; Strahinja P; Vargiu A; Poluzzi E; Montanaro N.
A 5 years surveillance of antibiotic use and microbiological resistance in an Italian university hospital.
2009 Silvani M.C.; Poluzzi E.; Motola D.; Quaranta P.; Nanetti A.; Ambretti S.; Fiacchi P.; Puggioli C.; Vaccheri A.; Montanaro N.
Aderenza alla terapia antidepressiva in Emilia-Romagna
2012 Poluzzi E; Sangiorgi E; Piccinni C; Clo M
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage
2007 Poluzzi E.; Strahinja P.; Vaccheri A.; Vargiu A.; Silvani M.C.; Motola D.; Marchesini G.; De Ponti F.; Montanaro N.
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage.
2006 Poluzzi E; Strahinja P; Vargiu A; Silvani MC; Motola D; Vaccheri A; De Ponti F; Marchesini Reggiani G; Montanaro N.
Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy
2008 Poluzzi E; Strahinja P; Lanzoni M; Vargiu A; Silvani MC; Motola D; Gaddi A; Vaccheri A; Montanaro N.
Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System
2022 Raschi E.; Fusaroli M.; Giunchi V.; Repaci A.; Pelusi C.; Mollica V.; Massari F.; Ardizzoni A.; Poluzzi E.; Pagotto U.; Di Dalmazi G.
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies
2015 Roberto, G; Raschi, E.; Piccinni, C.; Conti, V.; Vignatelli, L.; D'Alessandro, R.; De Ponti, F.; Poluzzi, E.
Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems
2018 Raschi, Emanuel*; Girardi, Anna; Poluzzi, Elisabetta; Forcesi, Emanuele; Menniti-Ippolito, Francesca; Mazzanti, Gabriela; De Ponti, Fabrizio
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems
2017 Raschi, E.; Parisotto, M.; Forcesi, E.; La Placa, M.; Marchesini, G.; De Ponti, F.; Poluzzi, E.
Adverse pregnancy outcomes in women exposed to gabapentin and pregabalin: data from a population-based study
2018 Mostacci, Barbara; Poluzzi, Elisabetta; D'Alessandro, Roberto; Cocchi, Guido; Tinuper, Paolo
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System
2022 Gaimari A.; Fusaroli M.; Raschi E.; Baldin E.; Vignatelli L.; Nonino F.; De Ponti F.; Mandrioli J.; Poluzzi E.
An approach to evaluate appropriateness in the antibacterial therapy in Italian hospitals.
2007 Silvani MC; Bersaglia L; Poluzzi E; Motola D; Bottoni A; Strahinja P; Vargiu A; Vaccheri A; Montanaro N.
An update on the first decade of the European centralized procedure: how many innovative drugs?
2006 Motola D.; De Ponti F.; Poluzzi E.; Martini N.; Rossi P.; Silvani M.C.; Vaccheri A.; Montanaro N.
Analyses of natalizumab prescriptions and discontinuations in multiple sclerosis patients of an Italian region
2011 Sacripanti C; Piccinni C; Puccini A; Poluzzi E; Montanaro N
Antibacterial macrolides: a drug class with a complex pharmacological profile
2004 ABU-GHARBIEH E.; VASINA V.; POLUZZI E.; DE PONTI F.
Antibiotic Use and Microbiological Surveillance: An Ecological Study in an Italian University Hospital.
2008 M. C. Silvani; L. Bersaglia; E. Poluzzi; D. Motola; A. Nanetti; S. Ambretti; A. Bottoni; A. Vaccheri; N. Montanaro.
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy
2021 Baldin E.; Zenesini C.; Antonazzo I.C.; Bartolomei I.; Caniatti L.; Costa M.; Curti E.; Ferraro D.; Foschi M.; Granella F.; Guareschi A.; Immovilli P.; Lugaresi A.; Malagu S.; Mancinelli L.; Montepietra S.; Mussuto V.; Neri W.; Pasquinelli M.; Pellegrino L.; Pesci I.; Poluzzi E.; Pugliatti M.; Ravasio A.; Riise T.; Salvi F.; Santangelo M.; Sireci F.; Sola P.; Strumia S.; Tsantes E.; Vignatelli L.; Vitetta F.; Viti B.; D'Alessandro R.
Antibiotic use in Italian hospitals 2002-2004.
2006 Silvani MC; Poluzzi E; Motola D; Strahinja P; Vargiu A; Bersaglia L; Vaccheri A; Montanaro N.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| 'Use of antipsychotics in children and adolescents: A picture from the ARITMO population-based European cohort study' | Kaguelidou F.; Holstiege J.; Schink T.; Bezemer I.; Poluzzi E.; Mazzaglia G.; Pedersen L.; Sturke...nboom M.; Trifiro G. | 2020-01-01 | EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES | - | 1.01 Articolo in rivista | use-of-antipsychotics-in-children-and-adolescents-a-picture-from-the-aritmo-population-based-european-cohort-study.pdf |
| A 3 year survey on the use of antibacterial agents in five Italian hospitals. | Vaccheri A; Silvani MC; Bersaglia L; Motola D; Strahinja P; Vargiu A; Poluzzi E; Montanaro N. | 2008-01-01 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | - | 1.01 Articolo in rivista | - |
| A 5 years surveillance of antibiotic use and microbiological resistance in an Italian university hospital. | Silvani M.C.; Poluzzi E.; Motola D.; Quaranta P.; Nanetti A.; Ambretti S.; Fiacchi P.; Puggioli C....; Vaccheri A.; Montanaro N. | 2009-01-01 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Aderenza alla terapia antidepressiva in Emilia-Romagna | Poluzzi E; Sangiorgi E; Piccinni C; Clo M | 2012-01-01 | ISTISAN CONGRESSI | - | 4.02 Riassunto (Abstract) | - |
| Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage | Poluzzi E.; Strahinja P.; Vaccheri A.; Vargiu A.; Silvani M.C.; Motola D.; Marchesini G.; De Pont...i F.; Montanaro N. | 2007-01-01 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. | Poluzzi E; Strahinja P; Vargiu A; Silvani MC; Motola D; Vaccheri A; De Ponti F; Marchesini Reggia...ni G; Montanaro N. | 2006-01-01 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | - | 4.02 Riassunto (Abstract) | - |
| Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy | Poluzzi E; Strahinja P; Lanzoni M; Vargiu A; Silvani MC; Motola D; Gaddi A; Vaccheri A; Montanaro N. | 2008-01-01 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System | Raschi E.; Fusaroli M.; Giunchi V.; Repaci A.; Pelusi C.; Mollica V.; Massari F.; Ardizzoni A.; P...oluzzi E.; Pagotto U.; Di Dalmazi G. | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-14-04610-v2 (2).pdf |
| Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies | Roberto, G; Raschi, E.; Piccinni, C.; Conti, V.; Vignatelli, L.; D'Alessandro, R.; De Ponti, F.; ...Poluzzi, E. | 2015-01-01 | CEPHALALGIA | - | 1.01 Articolo in rivista | - |
| Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems | Raschi, Emanuel*; Girardi, Anna; Poluzzi, Elisabetta; Forcesi, Emanuele; Menniti-Ippolito, France...sca; Mazzanti, Gabriela; De Ponti, Fabrizio | 2018-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | - |
| Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems | Raschi, E.; Parisotto, M.; Forcesi, E.; La Placa, M.; Marchesini, G.; De Ponti, F.; Poluzzi, E. | 2017-01-01 | NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES | - | 1.01 Articolo in rivista | j.numecd.2017.10.008.pdf |
| Adverse pregnancy outcomes in women exposed to gabapentin and pregabalin: data from a population-based study | Mostacci, Barbara; Poluzzi, Elisabetta; D'Alessandro, Roberto; Cocchi, Guido; Tinuper, Paolo | 2018-01-01 | JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY | - | 1.04 Replica / breve intervento (e simili) | - |
| Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System | Gaimari A.; Fusaroli M.; Raschi E.; Baldin E.; Vignatelli L.; Nonino F.; De Ponti F.; Mandrioli J....; Poluzzi E. | 2022-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | Amyotrophic.pdf |
| An approach to evaluate appropriateness in the antibacterial therapy in Italian hospitals. | Silvani MC; Bersaglia L; Poluzzi E; Motola D; Bottoni A; Strahinja P; Vargiu A; Vaccheri A; Monta...naro N. | 2007-01-01 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | - | 4.02 Riassunto (Abstract) | - |
| An update on the first decade of the European centralized procedure: how many innovative drugs? | Motola D.; De Ponti F.; Poluzzi E.; Martini N.; Rossi P.; Silvani M.C.; Vaccheri A.; Montanaro N. | 2006-01-01 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Analyses of natalizumab prescriptions and discontinuations in multiple sclerosis patients of an Italian region | Sacripanti C; Piccinni C; Puccini A; Poluzzi E; Montanaro N | 2011-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Antibacterial macrolides: a drug class with a complex pharmacological profile | ABU-GHARBIEH E.; VASINA V.; POLUZZI E.; DE PONTI F. | 2004-01-01 | PHARMACOLOGICAL RESEARCH | - | 1.01 Articolo in rivista | - |
| Antibiotic Use and Microbiological Surveillance: An Ecological Study in an Italian University Hospital. | M. C. Silvani; L. Bersaglia; E. Poluzzi; D. Motola; A. Nanetti; S. Ambretti; A. Bottoni; A. Vacch...eri; N. Montanaro. | 2008-01-01 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | - | 4.02 Riassunto (Abstract) | - |
| Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy | Baldin E.; Zenesini C.; Antonazzo I.C.; Bartolomei I.; Caniatti L.; Costa M.; Curti E.; Ferraro D....; Foschi M.; Granella F.; Guareschi A.; Immovilli P.; Lugaresi A.; Malagu S.; Mancinelli L.; Montepietra S.; Mussuto V.; Neri W.; Pasquinelli M.; Pellegrino L.; Pesci I.; Poluzzi E.; Pugliatti M.; Ravasio A.; Riise T.; Salvi F.; Santangelo M.; Sireci F.; Sola P.; Strumia S.; Tsantes E.; Vignatelli L.; Vitetta F.; Viti B.; D'Alessandro R. | 2021-01-01 | NEUROEPIDEMIOLOGY | - | 1.01 Articolo in rivista | - |
| Antibiotic use in Italian hospitals 2002-2004. | Silvani MC; Poluzzi E; Motola D; Strahinja P; Vargiu A; Bersaglia L; Vaccheri A; Montanaro N. | 2006-01-01 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | - | 4.02 Riassunto (Abstract) | - |